Prescription opioid availability and opioid overdose-related mortality rates in Medicaid expansion and non-expansion states.

Increases in Medicaid-reimbursed prescription opioid availability in Affordable Care Act Medicaid expansion states in the United States do not appear to have mediated post-Affordable Care Act Medicaid expansion mortality rate differences, but there is still a possibility of lagged effects.